Germany buys the first antibody drug in the EU, 200 thousand doses ready for use

German Health Minister now decided on the purchase of 200,000 doses of a drug that apparently even helped former US President Trump.

The German government has purchased a new anti-Coona drug based on antibodies for Germany. Next week's “will use monochlonal antibodies in Germany as the first country in the EU. At first in university clinics”, German Health Minister Jens Spahn told the German newspaper “Bild am Sonntag”. “Federata acquired 200,000 doses for 400m euros.” That is, for a dose of price, 2,000 euros.

A Milder Walking of the Disease in Risk Patients

With this drug of antibodies, the U.S. President Donald Trump has also been treated with reports of Corona infection. “They act as a passive inoculation. Giving such antibodies can help endangered groups of patients in the early phase of the disease by preventing its serious performance”, German CDU politician Spahn has indicated.

In early October Donald Trump was treated with an antibodies cocktail. GEN-COV2 of the American firm Regeneron.

GRUN-COV2's substance is a special combination of two antibodies, blocking the so-called Corona virus protein and thus distorting its structure. Thus it prevents the Corona virus from affecting human cells in the body and multiplying. The combination of two antibodies, according to the American concert Regeneron, prevents the SARS-COV2 virus from mutating.

In conversation with the German newspaper, German Health Minister Jens Spahn expressed added caution in dealing with pandemics. talking about error or loss of chance is important. But without going to war ruthlessly. With no intent to drop blame on others”, Spahn said.